The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development
Open accessAbstract
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that recently re-emerged in many parts of the world causing large-scale outbreaks. CHIKV infection presents as a febrile illness known as chikungunya fever (CHIKF). Infection is self-limited and characterized mainly by severe joint pain and myalgia that can last for weeks or months; however, severe disease presentation can also occur in a minor proportion of infections. Among the atypical CHIKV manifestations that have been described, severe arthralgia and neurological complications, such as encephalitis, meningitis, and Guillain–Barré Syndrome, are now reported in many outbreaks. Moreover, death cases were also reported, placing CHIKV as a relevant public health disease. Virus evolution, globalization, and climate change may have contributed to CHIKV spread. In addition to this, the lack of preventive vaccines and approved antiviral treatments is turning CHIKV into a major global health threat. In this review, we discuss the current knowledge about CHIKV pathogenesis, with a focus on atypical disease manifestations, such as persistent arthralgia and neurologic disease presentation. We also bring an up-to-date review of the current CHIKV vaccine development. Altogether, these topics highlight some of the most recent advances in our understanding of CHIKV pathogenesis and also provide important insights into the current development and clinical trials of CHIKV potential vaccine candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination
Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2104840 · Cited by 2,259 · cited 1×
“However, given the wide use of the SARS-CoV-2 vaccine ChAdOx1-S, significant adverse effects started to be reported, these include thrombocytopenia and major arterial and venous thrombosis [121] that were associated with a rare development of immune thrombotic thrombocytopenia mediated by platelet-activating antibodie…”
BackgroundA Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential
Tsetsarkin, K. A., Vanlandingham, D. L., McGee, C. E., & Higgs, S. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030201 · Cited by 1,630
Infection with chikungunya virus in Italy: an outbreak in a temperate region
Rezza, G., Nicoletti, L., Angelini, R., Romi, R., Finarelli, A., Panning, M., Cordioli, P., Fortuna, C., Boros, S., Magurano, F., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61779-6 · Cited by 1,527
Global expansion and redistribution of Aedes-borne virus transmission risk with climate change
Ryan, S. J., Carlson, C. J., Mordecai, E. A., & Johnson, L. R. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007213 · Cited by 1,114
An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953
Robinson, M. C. (1955) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(55)90080-8 · Cited by 995
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
Voss, J. E., Vaney, M.-C., Duquerroy, S., Vonrhein, C., Girard-Blanc, C., Crublet, E., Thompson, A., Bricogne, G., & Rey, F. A. (2010) · Nature · doi:10.1038/nature09555 · Cited by 696
Ross, R. W. (1956) · Journal of Hygiene · doi:10.1017/s0022172400044442 · Cited by 649
Hoarau, J.-J., Jaffar Bandjee, M.-C., Krejbich Trotot, P., Das, T., Li-Pat-Yuen, G., Dassa, B., Denizot, M., Guichard, E., Ribera, A., Henni, T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900255 · Cited by 640
Couderc, T., Chrétien, F., Schilte, C., Disson, O., Brigitte, M., Guivel-Benhassine, F., Touret, Y., Barau, G., Cayet, N., Schuffenecker, I., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040029 · Cited by 620
Silva, L. A., & Dermody, T. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84417 · Cited by 595
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages
Labadie, K., Larcher, T., Joubert, C., Mannioui, A., Delache, B., Brochard, P., Guigand, L., Dubreil, L., Lebon, P., Verrier, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40104 · Cited by 589
Leparc-Goffart, I., Nougairede, A., Cassadou, S., Prat, C., & de Lamballerie, X. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60185-9 · Cited by 559
Emergence and potential for spread of Chikungunya virus in Brazil
Nunes, M. R. T., Faria, N. R., de Vasconcelos, J. M., Golding, N., Kraemer, M. U., de Oliveira, L. F., Azevedo, R. D. S. D. S., da Silva, D. E. A., da Silva, E. V. P., da Silva, S. P., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0348-x · Cited by 531
Borgherini, G., Poubeau, P., Staikowsky, F., Lory, M., Moullec, N. L., Becquart, J. P., Wengling, C., Michault, A., & Paganin, F. (2007) · Clinical Infectious Diseases · doi:10.1086/517537 · Cited by 522
Gérardin, P., Barau, G., Michault, A., Bintner, M., Randrianaivo, H., Choker, G., Lenglet, Y., Touret, Y., Bouveret, A., Grivard, P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050060 · Cited by 521
Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases
Weaver, S. C., Charlier, C., Vasilakis, N., & Lecuit, M. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-105122 · Cited by 501
Chikungunya Outbreaks — The Globalization of Vectorborne Diseases
Charrel, R. N., de Lamballerie, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078013 · Cited by 459
Mxra8 is a receptor for multiple arthritogenic alphaviruses
Zhang, R., Kim, A. S., Fox, J. M., Nair, S., Basore, K., Klimstra, W. B., Rimkunas, R., Fong, R. H., Lin, H., Poddar, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0121-3 · Cited by 448
Sissoko, D., Malvy, D., Ezzedine, K., Renault, P., Moscetti, F., Ledrans, M., & Pierre, V. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000389 · Cited by 419
Chow, A., Her, Z., Ong, E. K. S., Chen, J.-M., Dimatatac, F., Kwek, D. J. C., Barkham, T., Yang, H., Rénia, L., Leo, Y.-S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq042 · Cited by 389
Human genetic and immunological determinants of critical COVID-19 pneumonia
Zhang, Q., Bastard, P., Effort, C. H. G., Karbuz, A., Gervais, A., Tayoun, A. A., Aiuti, A., Belot, A., Bolze, A., Gaudet, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04447-0 · Cited by 366
Jemielity, S., Wang, J. J., Chan, Y. K., Ahmed, A. A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G. J., Umetsu, D. T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003232 · Cited by 364
IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
Ng, L. F. P., Chow, A., Sun, Y.-J., Kwek, D. J. C., Lim, P.-L., Dimatatac, F., Ng, L.-C., Ooi, E.-E., Choo, K.-H., Her, Z., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004261 · Cited by 304
Gould, E. A., Gallian, P., de Lamballerie, X., & Charrel, R. N. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03386.x · Cited by 291
Role of the Phosphatidylserine Receptor TIM-1 in Enveloped-Virus Entry
Moller-Tank, S., Kondratowicz, A. S., Davey, R. A., Rennert, P. D., & Maury, W. (2013) · Journal of Virology · doi:10.1128/jvi.01025-13 · Cited by 285
Hawman, D. W., Stoermer, K. A., Montgomery, S. A., Pal, P., Oko, L., Diamond, M. S., & Morrison, T. E. (2013) · Journal of Virology · doi:10.1128/jvi.02666-13 · Cited by 248
The many projected futures of dengue
Messina, J. P., Brady, O. J., Pigott, D. M., Golding, N., Kraemer, M. U. G., Scott, T. W., Wint, G. R. W., Smith, D. L., & Hay, S. I. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3430 · Cited by 210
Infectious Clones of Chikungunya Virus (La Réunion Isolate) for Vector Competence Studies
Tsetsarkin, K., Higgs, S., McGee, C. E., Lamballerie, X. D., Charrel, R. N., & Vanlandingham, D. L. (2006) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2006.6.325 · Cited by 209
Identification of prohibitin as a Chikungunya virus receptor protein
Wintachai, P., Wikan, N., Kuadkitkan, A., Jaimipuk, T., Ubol, S., Pulmanausahakul, R., Auewarakul, P., Kasinrerk, W., Weng, W., Panyasrivanit, M., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23403 · Cited by 204
Kose, N., Fox, J. M., Sapparapu, G., Bombardi, R., Tennekoon, R. N., de Silva, A. D., Elbashir, S. M., Theisen, M. A., Humphris-Narayanan, E., Ciaramella, G., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw6647 · Cited by 202
Neurological complications of Chikungunya virus infection
Daginawala, H., Chandak, N., Kashyap, R., Kabra, D., Karandikar, P., Saha, S., Morey, S., Purohit, H., & Taori, G. (2009) · Neurology India · doi:10.4103/0028-3886.51289 · Cited by 198
Gorchakov, R., Wang, E., Leal, G., Forrester, N. L., Plante, K., Rossi, S. L., Partidos, C. D., Adams, A. P., Seymour, R. L., Weger, J., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06449-11 · Cited by 197
August, A., Attarwala, H. Z., Himansu, S., Kalidindi, S., Lu, S., Pajon, R., Han, S., Lecerf, J.-M., Tomassini, J. E., Hard, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01573-6 · Cited by 196
Reisinger, E. C., Tschismarov, R., Beubler, E., Wiedermann, U., Firbas, C., Loebermann, M., Pfeiffer, A., Muellner, M., Tauber, E., & Ramsauer, K. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32488-7 · Cited by 187
Alphavirus Entry and Membrane Fusion
Kielian, M., Chanel-Vos, C., & Liao, M. (2010) · Viruses · doi:10.3390/v2040796 · Cited by 178
Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses
Suhrbier, A., & La Linn, M. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000130537.76808.26 · Cited by 176
Kelvin, A. A., Banner, D., Silvi, G., Moro, M. L., Spataro, N., Gaibani, P., Cavrini, F., Pierro, A., Rossini, G., Cameron, M. J., et al. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001279 · Cited by 175
CHOPRA, A., ANURADHA, V., GHORPADE, R., & SALUJA, M. (2012) · Epidemiology and Infection · doi:10.1017/s0950268811001300 · Cited by 161
Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses
Trotot, P. K., Denizot, M., Hoarau, J., Jaffar‐Bandjee, M., Das, T., & Gasque, P. (2010) · The FASEB Journal · doi:10.1096/fj.10-164178 · Cited by 159
Brandler, S., Ruffié, C., Combredet, C., Brault, J., Najburg, V., Prévost, M., Habel, A., Tauber, E., Desprès, P., & Tangy, F. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.086 · Cited by 153
Silva, M. M. O., Tauro, L. B., Kikuti, M., dos Anjos, R. O., dos Santos, V. C. F., Gonçalves, T. S. F., Paploski, I. A. D., Moreira, P. S. S., Nascimento, L. C. J., Campos, G. S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1083 · Cited by 148
Hapuarachchi, H. C., Bandara, K., Sumanadasa, S. D. M., Hapugoda, M. D., Lai, Y., Lee, K., Tan, L.-K., Lin, R. T. P., Ng, L. F. P., Bucht, G., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.015743-0 · Cited by 145
Role of Proinflammatory Cytokines and Chemokines in Chronic Arthropathy in CHIKV Infection
Chaaithanya, I. K., Muruganandam, N., Sundaram, S. G., Kawalekar, O. U., Sugunan, A. P., Manimunda, S. P., Ghosal, S. R., Muthumani, K., & Vijayachari, P. (2011) · Viral Immunology · doi:10.1089/vim.2010.0123 · Cited by 140
Ferreira, M. L. B., de Albuquerque, M. D. F. P. M., de Brito, C. A. A., França, R. F. D. O., Moreira, Á. J. P., Machado, M. Í. D. M., Melo, R. D. P., Medialdea‐Carrera, R., Mesquita, S. D., Santos, M. L., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30232-5 · Cited by 137
Stapleford, K. A., Moratorio, G., Henningsson, R., Chen, R., Matheus, S., Enfissi, A., Weissglas‐Volkov, D., Isakov, O., Blanc, H., Mounce, B. C., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004402 · Cited by 131
Her, Z., Teng, T., Tan, J. J. L., Teo, T., Kam, Y., Lum, F., Lee, W. W. L., Gabriel, C., Melchiotti, R., Andiappan, A. K., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404459 · Cited by 129
Frequency of Chronic Joint Pain Following Chikungunya Virus Infection: A Colombian Cohort Study
Chang, A. Y., Encinales, L., Porras, A., Pacheco, N., Reid, S. P., Martins, K. A. O., Pacheco, S., Bravo, E., Navarno, M., Rico-Mendoza, A., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40384 · Cited by 126
Messaoudi, I., Totonchy, J. E., Totonchy, T., Kreklywich, C. N., Haberthur, K., Springgay, L., Brien, J. D., Diamond, M., DeFilippis, V. R., & Streblow, D. N. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002343 · Cited by 120
A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection
Teng, T., Kam, Y., Lee, B. T. K., Hapuarachchi, H. C., Abeyewickreme, W., Ng, L. C., & Ng, L. F. P. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv049 · Cited by 118
FHL1 is a major host factor for chikungunya virus infection
Meertens, L., Hafirassou, M. L., Couderc, T., Bonnet‐Madin, L., Kril, V., Kümmerer, B. M., Labeau, A., Brugier, A., Simon‐Lorière, E., Burlaud‐Gaillard, J., et al. (2019) · Nature · doi:10.1038/s41586-019-1578-4 · Cited by 118
Mehta, R., Soares, C., Medialdea‐Carrera, R., Ellul, M. A., da Silva, M. T. T., Rosala‐Hallas, A., Jardim, M. R., Burnside, G., Pamplona, L. D. A. E. L., Bhojak, M., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006212 · Cited by 112
Langsjoen, R. M., Haller, S. L., Roy, C. J., Vinet-Oliphant, H., Bergren, N. A., Erasmus, J. H., Livengood, J. A., Powell, T. D., Weaver, S. C., & Rossi, S. L. (2018) · mBio · doi:10.1128/mbio.02449-17 · Cited by 112
Wressnigg, N., Hochreiter, R., Zoihsl, O., Fritzer, A., Bézay, N., Klingler, A., Lingnau, K., Schneider, M., Lundberg, U., Meinke, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30238-3 · Cited by 111
Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes
Chen, G. L., Coates, E. E., Plummer, S. H., Carter, C. A., Berkowitz, N. M., Conan-Cibotti, M., Cox, J. H., Beck, A., O’Callahan, M., Andrews, C. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.2477 · Cited by 109
Antivirals against the Chikungunya Virus
Battisti, V., Urban, E., & Langer, T. (2021) · Viruses · doi:10.3390/v13071307 · Cited by 106
Interleukin 6, RANKL, and Osteoprotegerin Expression by Chikungunya Virus-Infected Human Osteoblasts
Noret, M., Herrero, L. J., Rulli, N. E., Rolph, M. S., Smith, P. N., Li, R., Roques, P., Gras, G. S., & Mahalingam, S. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis368 · Cited by 101
Whiteley, W. N., Ip, S., Cooper, J., Bolton, T., Keene, S. J., Walker, V. M., Denholm, R., Akbari, A., Omigie, E., Hollings, S., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003926 · Cited by 91
Agarwal, A., Dash, P. K., Singh, A. K., Sharma, S., Gopalan, N., Rao, P. V., Parida, M. M., & Reiter, P. L. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002990 · Cited by 86
Thanapati, S., Ganu, M. A., Giri, P. S., Kulkarni, S. P., Sharma, M., Babar, P., Ganu, A., & Tripathy, A. S. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.02.006 · Cited by 82
Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence
Hawman, D. W., Fox, J. M., Ashbrook, A. W., May, N. A., Schroeder, K., Torres, R. M., Crowe, J. E., Dermody, T. S., Diamond, M. S., & Morrison, T. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.076 · Cited by 80
Tritsch, S. R., Encinales, L., Pacheco, N., Cadena, A., Curé, C., McMahon, E., Watson, H., Porras, A., Mendoza, A. R., Li, G., et al. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190162 · Cited by 78
Folegatti, P. M., Harrison, K., Preciado‐Llanes, L., Lopez, F. R., Bittaye, M., Kim, Y. C., Flaxman, A. L., Bellamy, D. G., Makinson, R., Sheridan, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24906-y · Cited by 76
Wang, E., Kim, D., Weaver, S. C., & Frolov, I. V. (2011) · Journal of Virology · doi:10.1128/jvi.00844-11 · Cited by 75
Acosta, M. P., Geoghegan, E. M., Lepenies, B., Ruzal, S. M., Kielian, M. C., & Martínez, M. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00810 · Cited by 73
Dhanwani, R., Khan, M. A., Bhaskar, A. S. B., Singh, R., Patro, I. K., Rao, P. V., & Parida, M. (2011) · Virus Research · doi:10.1016/j.virusres.2011.12.009 · Cited by 70
Cellular Attachment and Entry Factors for Chikungunya Virus
Schnierle, B. S. (2019) · Viruses · doi:10.3390/v11111078 · Cited by 68
Association of toll-like receptor polymorphisms with susceptibility to chikungunya virus infection
Dutta, S. K., & Tripathi�, A. (2017) · Virology · doi:10.1016/j.virol.2017.08.009 · Cited by 67
Involvement of ATP synthase β subunit in chikungunya virus entry into insect cells
Fongsaran, C., Jirakanwisal, K., Kuadkitkan, A., Wikan, N., Wintachai, P., Thepparit, C., Ubol, S., Phaonakrop, N., Roytrakul, S., & Smith, D. R. (2014) · Archives of Virology · doi:10.1007/s00705-014-2210-4 · Cited by 64
Current and Promising Antivirals Against Chikungunya Virus
Hucke, F. I. L., & Bugert, J. J. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.618624 · Cited by 64
The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry
Kirui, J., Abidine, Y., Lenman, A., Islam, K., Gwon, Y.-D., Laßwitz, L., Evander, M., Bally, M., & Gerold, G. (2021) · Cells · doi:10.3390/cells10071828 · Cited by 58
Sahadeo, N. S. D., Mohammed, H. P., Allicock, O. M., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004199 · Cited by 53
Fraisier, C., Koraka, P., Belghazi, M., Bakli, M., Granjeaud, S., Pophillat, M., Lim, S. M., Osterhaus, A. D. M. E., Martina, B. E. E., Camoin, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091397 · Cited by 51
Chiam, C. W., Chan, Y. F., Ong, K. C., Wong, K. T., & Sam, I. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000263 · Cited by 48
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Baldo, A., Galanis, E., Tangy, F., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1122146 · Cited by 47
Plante, K. S., Rossi, S. L., Bergren, N. A., Seymour, R. L., & Weaver, S. C. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004007 · Cited by 46
Interactions of Alphavirus nsP3 Protein with Host Proteins
Lark, T., Keck, F., & Narayanan, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02652 · Cited by 45
Caluwé, L. D., Coppens, S., Vereecken, K., Daled, S., Dhaenens, M., Ostade, X. V., Deforce, D. L. D., Ariën, K. K., & Bartholomeeusen, K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.615165 · Cited by 45
Pott, F., Postmus, D., Brown, R. J. P., Wyler, E., Neumann, E., Landthaler, M., & Goffinet, C. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2000891 · Cited by 35
Jacob-Nascimento, L. C., de Carvalho, C. X., Silva, M. M. O., Kikuti, M., dos Anjos, R. O., Fradico, J. R. B., Campi‐Azevedo, A. C., Tauro, L. B., Campos, G. S., Moreira, P. S. D. S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744183 · Cited by 29
Mendoza‐Cano, O., Murillo‐Zamora, E., Trujillo-Hernández, B., Sánchez-Piña, R. A., & Guzmán-Esquivel, J. (2017) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2017.72 · Cited by 28
Nair, S. R., Abraham, R., Sundaram, S., & Sreekumar, E. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0583-3 · Cited by 26
Cited by
Bartholomeeusen, K., Daniel, M., LaBeaud, D. A., Gasque, P., Peeling, R. W., Stephenson, K. E., Ng, L. F. P., & Ariën, K. K. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00429-2 · Cited by 297
AGPAT1 is a novel Chikungunya virus receptor on human cells
Basu, B., Sarmadhikari, D., Sharma, A., Asthana, S., Kalia, M., & Vrati, S. (2026) · Journal of Virology · doi:10.1128/jvi.01733-25
Metadata
- Authors
- de Lima Cavalcanti, T. Y. V., Pereira, M. R., de Paula, S. O., & Franca, R. F. D. O.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2022-05-05
- Volume
- 14
- Issue
- 5
- Pages
- 969
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W4229009493
- Cited by
- 259
- References
- 81
- FWCI
- 39.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.